Rebekah Leigh Wyrosdick, FNP-C, MSN

Rebekah Wyrosdick practices at Baptist Hospital - Urgent Care in Pensacola, Florida.

Rebekah Wyrosdick's NPI, 1760948665, was assigned on February 15, 2019. Rebekah Wyrosdick graduated from University of South Alabama College of Medicine in 2018. Rebekah Wyrosdick holds Florida license APRN11001465.

Rebekah Wyrosdick's primary practice is Baptist Hospital - Urgent Care, at 1000 W Moreno St, Pensacola, FL 32501. The practice phone is (850) 908-8888.

Rebekah Wyrosdick's primary practice is Baptist Hospital - Urgent Care in Pensacola, Florida. Rebekah Wyrosdick is also affiliated with Baptist Hospital. The medical group on file is Baptist Medical Group Ladies First OB/GYN. Dmand AI also links Rebekah Wyrosdick to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rebekah Wyrosdick practices, 7 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Rebekah Wyrosdick's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Rebekah Wyrosdick is licensed in Florida.

Dmand AI lists depression, diabetic emergency, fluid and electrolyte imbalances, high cholesterol, sleep apnea and tobacco use among the conditions Rebekah Wyrosdick treats.

CMS data shows 510 Medicare services from Rebekah Wyrosdick across 5 procedure codes in 2024, for 244 Medicare patients. Medicare paid $32,201 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 244 Medicare patients who saw Rebekah Wyrosdick in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have heart failure, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rebekah Wyrosdick's median patient age at 70, with 62% women.

In 2024, Rebekah Wyrosdick wrote 1,659 Medicare Part D claims for 335 patients. 70% of them were for generic drugs. CMS names the drug for 1,436 of them, across 24 drugs with 11 or more claims each, at $357,052 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Rebekah Wyrosdick for performance year 2024, reported as part of a group. Rebekah Wyrosdick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Rebekah Wyrosdick from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 84% of the total. Abbott Laboratories paid the most, $111.

Rebekah Wyrosdick graduated from University of South Alabama College of Medicine in 2018.